The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schobel Alexander Mark since 2018.
This trader's CIK number is 1406836.
At the time of last reporting, Schobel Alexander Mark was the Chief Innovation/Tech Officer of Aquestive Therapeutics, Inc.. (stock ticker symbol AQST).
Also see all insider trading activities at Aquestive Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AQST | 0 | $0 | 75,000 | $429,675 | 0 | $0 |
| 2022 | AQST | 45,871 | $44,036 | 0 | $0 | 0 | $0 |
| 2021 | AQST | 0 | $0 | 75,792 | $501,398 | 0 | $0 |
| 2020 | AQST | 0 | $0 | 160,000 | $688,000 | 30,135 | $0 |
| 2019 | AQST | 0 | $0 | 0 | $0 | 59,604 | $0 |
| 2018 | AQST | 4,000 | $35,410 | 0 | $0 | 29,473 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-15 | AQST | Sale | 50,000 | 6.00 | 300,000 |
| 2024-03-08 | AQST | Sale | 25,000 | 5.19 | 129,675 |
| 2022-06-08 | AQST | Buy | 45,871 | .96 | 44,036 |
| 2021-02-09 | AQST | Sale | 11,540 | 6.75 | 77,895 |
| 2021-02-10 | AQST | Sale | 23,460 | 6.75 | 158,355 |
| 2021-02-08 | AQST | Sale | 40,792 | 6.50 | 265,148 |
| 2020-06-30 | AQST | Option Ex | 333 | .00 | 0 |
| 2020-05-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2020-05-08 | AQST | Sale | 40,000 | 5.00 | 200,000 |
| 2020-04-14 | AQST | Sale | 40,000 | 3.70 | 148,000 |
| 2020-04-27 | AQST | Sale | 40,000 | 4.00 | 160,000 |
| 2020-04-29 | AQST | Sale | 40,000 | 4.50 | 180,000 |
| 2020-03-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2020-02-29 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-11-30 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-09-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-08-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-06-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-05-31 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2019-03-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2019-02-28 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2018-12-31 | AQST | Option Ex | 329 | .00 | 0 |
| 2018-12-10 | AQST | Buy | 1,000 | 7.78 | 7,780 |
| 2018-12-06 | AQST | Buy | 2,000 | 8.69 | 17,380 |
| 2018-11-30 | AQST | Option Ex | 14,572 | .00 | 0 |
| 2018-11-21 | AQST | Buy | 1,000 | 10.25 | 10,250 |
| 2018-09-30 | AQST | Option Ex | 329 | .00 | 0 |
| 2018-08-31 | AQST | Option Ex | 14,572 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schobel Alexander Mark (Chief Innovation/Tech Officer of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.